Bobbie Pharmaceutical Services
0799.344.237 · rovalta.com · 22/09/2026
Bobbie Pharmaceutical Services
Overview
What does Bobbie Pharmaceutical Services do?
Bobbie Pharmaceutical Services is a Private limited company incorporated in 2023. Its main activity is: Activities of holding companies. Its registered office is in Wingene.
8750 Wingene · FlandreSee on map
Trend over 3 financial years
| 2025 | 2024 | 2024 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 1,5 M € | -21.8% | 2 M € | – | |
| EBITDA | 162,4 k € | -90.3% | 1,7 M € | +66.7% | 1 M € |
| Operating result | 74,3 k € | -95.5% | 1,7 M € | +66.2% | 998 k € |
| Net result | -1,2 M € | -171% | 1,6 M € | -44.5% | 2,9 M € |
| Balance sheet | |||||
| Equity | 17,5 M € | +79.2% | 9,8 M € | +19.8% | 8,2 M € |
| Total assets | 47 M € | +40.9% | 33,3 M € | -2.2% | 34,1 M € |
| Cash | 79,7 k € | -4.3% | 83,3 k € | +730% | 10 k € |
| Debts | 29 M € | +24.6% | 23,2 M € | -8.8% | 25,5 M € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 7 active · 7 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
BOFAR● Active | 0425.935.908 |
VERGEL● Active | 0812.259.489 |
VERGEL GROUP● Active | 1026.206.055 |
Financials
Full financial information
| 2025 | 2024 | 2024 | |
|---|---|---|---|
| Type of account | Full model | Full model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/04/2024 | 09/03/2023 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/03/2024 |
| Length of the financial year | 12 months | 9 months | 13 months |
| Filing date | 03/07/2026 | 23/07/2025 | 26/09/2024 |
| General meeting | 30/06/2026 | 27/06/2025 | 29/08/2024 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
3 filings with the NBB
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 7 active · 7 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates15/10/2025ONTSLAGEN - BENOEMINGEN
- Restructuring14/04/2025KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring14/01/2025RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Other03/01/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ALGEMENE VERGADERING - BOEKJAAR
- Other13/03/2023RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-1,2 M €↓
- 2025Name changeBOPHAS - Bobbie Pharmaceutical Services
- 2024Annual accounts 20241,6 M €↓
- 2024Annual accounts 20242,9 M €
- 2024Name changeBobbie Pharmaceutical Services
- 09/03/2023IncorporationPrivate limited company